New treatment reduces heart scarring and abnormal heart rhythms, offering a possibility for future therapies
In a study led by Baylor College of Medicine and the University of Oxford, researchers found that blocking a specific molecular interaction reduced atrial fibrosis in mouse models and cells from human patients with atrial fibrillation (AF), reduced fibrotic responses in human cells, and in the mouse models reversed established atrial fibrosis and reduced abnormal heart rhythms.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Human skin models reveal how herpes spreads unevenly among neighboring cells
Science
Biology
Germany
-
Team publishes largest-ever dataset on real-world psychedelic support interactions
Science
Research
Global
-
Can creatine help your mental health? Here's what the latest evidence says
Health
Medicine
-
Post-COVID syndrome: Prednisolone shows modest, short-lived lift in treatment trial
Health
Medicine
-
Breast cancer drug raises creatinine without necessarily signaling kidney damage, study finds
Health
Medicine
Japan
-
How mental health and cancer survivorship intersect
Health
Mental Health
United States
-
Why some patients quit a newer insomnia medication
Health
Medicine
-
Alcohol use held steady among cancer survivors
Health
Medicine
United States